|
NAGE Niagen Bioscience Inc 1386570 |
| Balance Sheet |
|
Current Assets
|
$97,786,000.00 |
|
Assets
|
$106,589,000.00 |
|
Current Liabilities
|
$15,050,000.00 |
|
Liabilities
|
$24,061,000.00 |
|
Equity
|
$82,528,000.00 |
|
Shares Out
|
78908000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$1,578,000.00 |
|
Investing Cash Flow
|
$5,153,000.00 |
| Market Analysis |
Market Cap
|
$248,560,200.00 |
|
Price
|
$3.15 |
|
BVPS
|
1.05 |
|
PB
|
3.00 |
|
EPS
|
0.01 |
|
PS
|
2.09 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:45 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:36 |
|
| Apr |
May |
Jun |
| 2026-03-04 |
0.05 |
|
|
2026-05-06 |
0.07 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
0.04 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-04 |
0.05 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NAGE documents filed with the SEC.
NAGE Filings
Clear
